PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
78698252 |
LAW OFFICE ASSIGNED |
LAW OFFICE 113 |
MARK SECTION |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
INFANRIX-IPV |
OWNER SECTION (current) |
NAME |
SmithKline Beecham p.l.c. |
STREET |
980 Great West Road, Brentford |
CITY |
Middlesex |
ZIP/POSTAL CODE |
TW8 9BD |
COUNTRY |
United Kingdom |
OWNER SECTION (proposed) |
NAME |
SmithKline Beecham p.l.c. |
STREET |
980 Great West Road |
CITY |
Brentford, Middlesex |
ZIP/POSTAL CODE |
TW8 9BD |
COUNTRY |
England |
ATTORNEY SECTION (current) |
NAME |
Pamela A. May |
FIRM NAME |
709 SWEDELAND RD # UW2221 |
CITY |
KING OF PRUSSIA |
STATE |
Pennsylvania |
POSTAL CODE |
19406-2711 |
COUNTRY |
United States |
PHONE |
610-270-4479 |
FAX |
610-270-4440 |
EMAIL |
trademarks@gsk.com |
ATTORNEY DOCKET NUMBER |
App/INFANRIX |
ATTORNEY SECTION (proposed) |
NAME |
Pamela A. May |
FIRM NAME |
GlaxoSmithKline |
INTERNAL ADDRESS |
UW2221 |
STREET |
709 SWEDELAND RD |
CITY |
KING OF PRUSSIA |
STATE |
Pennsylvania |
POSTAL CODE |
19406-2711 |
COUNTRY |
United States |
PHONE |
610-270-4479 |
FAX |
610-270-4440 |
EMAIL |
trademarks@gsk.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
ATTORNEY DOCKET NUMBER |
App/INFANRIX |
OTHER APPOINTED ATTORNEY |
Teresa H. Anzalone; Scott E. Thompson; Maribeth D. Case |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
VACCINES FOR HUMAN USE |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research development |
ALLOWANCE MAIL DATE |
08/15/2006 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/pamela/ |
SIGNATORY'S NAME |
Pamela A. May |
SIGNATORY'S POSITION |
Trademark Director |
DATE SIGNED |
07/26/2007 |
FILING INFORMATION |
SUBMIT DATE |
Thu Jul 26 15:49:44 EDT 2007 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XX.XXX-
20070726154944471499-7869
8252-380f5da657736cb24f98
1aa5f7ccad4a181-DA-829-20
070726153031625709 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: INFANRIX-IPV
SERIAL NUMBER: 78698252
The applicant, SmithKline Beecham p.l.c., having an address of 980 Great West Road, Brentford, Middlesex, England TW8 9BD, requests a six-month extension of time to file the Statement of Use under 37
C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 08/15/2006.
For International Class 005:
Current identification: VACCINES FOR HUMAN USE
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development
The applicant hereby appoints Pamela A. May and Teresa H. Anzalone; Scott E. Thompson; Maribeth D. Case of GlaxoSmithKline, UW2221, 709 SWEDELAND RD, KING OF PRUSSIA, Pennsylvania United States
19406-2711 to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant. The attorney docket/reference number is App/INFANRIX.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /pamela/ Date Signed: 07/26/2007
Signatory's Name: Pamela A. May
Signatory's Position: Trademark Director
Mailing Address:
709 SWEDELAND RD # UW2221
KING OF PRUSSIA, Pennsylvania 19406-2711
Mailing Address:
GlaxoSmithKline
UW2221
709 SWEDELAND RD
KING OF PRUSSIA, Pennsylvania 19406-2711
RAM Sale Number: 829
RAM Accounting Date: 07/27/2007
Serial Number: 78698252
Internet Transmission Date: Thu Jul 26 15:49:44 EDT 2007
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.XXX-200707261549444
71499-78698252-380f5da657736cb24f981aa5f
7ccad4a181-DA-829-20070726153031625709